证券代码：603281 证券简称：江瀚新材 公告编号：2023-028 湖北江瀚新材料股份有限公司 参加 2023 年湖北辖区上市公司投资者 网上集体接待日活动预告公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 5 月 25 日（星期四）下午 14:30-16:35 会议召开地点：全景路演（http://rs.p5w.net） 会议召开方式：网络文字互动 投资者可于 2023 年 5 月 24 日（周三）17:00 前登全景路演"问题征 集专题"栏目（https://ir.p5w.net/zj）或通过公司邮箱 （irm@jhsi.biz）进行提问。公司将在本次活动上对投资者普遍关注 的问题进行回答。 一、说明会类型 为便于广大投资者全面了解公司经营成果和财务状况，湖北江瀚新材料股 份有限公司（以下简称"公司"）计划参加由湖北证监局、湖北省上市公司协 会、深圳市全景网络有限公司联合举办的"提高发展质量 切实回报股东"— 2023 年湖北辖区上市公司投资者网上集体接待日活动，通过网 ...

证券代码：603281 证券简称：江瀚新材 公告编号：2023-026 湖北江瀚新材料股份有限公司 2022 年度暨 2023 年第一季度业绩说明会预告公告 （一）会议召开时间：2023 年 6 月 1 日（星期四）下午 16:00-17:00 1 会议召开时间：2023 年 6 月 1 日（星期四）下午 16:00-17:00 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 5 月 25 日（星期四）至 5 月 31 日（星期三） 16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过 公司邮箱 irm@jhsi.biz 进行提问。公司将在说明会上对投资者普遍 关注的问题进行回答。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、说明会类型 湖北江瀚新材料股份有限公司（以下简称"公司"）已分别于 2023 年 4 月 25 日和 4 月 29 日发布公司 2022 年年度报 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥580,955,839.17, representing a decrease of 39.53% compared to the same period last year[13] - Net profit attributable to shareholders was ¥154,388,156.99, down 49.07% year-on-year[13] - The net profit after deducting non-recurring gains and losses was ¥144,617,732.31, reflecting a decline of 50.60% compared to the previous year[13] - Basic and diluted earnings per share were both ¥0.63, down 58.33% from the same period last year[14] - Operating profit for the first quarter was CNY 178,365,035.55, down 49% from CNY 350,672,196.58 year-over-year[24] - Total profit for the quarter was CNY 178,432,755.51, a decline of 49% from CNY 351,717,779.58 in the previous year[24] - The total comprehensive income for the quarter was CNY 154,388,156.99, down 49% from CNY 303,127,916.99 in the same period last year[24] Cash Flow - The net cash flow from operating activities was ¥55,993,785.62, a significant drop of 77.95% year-on-year[13] - The net cash flow from operating activities was ¥55,993,785.62, down 78.0% from ¥253,976,106.45 in the same period last year[38] - The net cash flow from investment activities was -¥909,150,027.63, worsening from -¥188,793,283.85 year-on-year[38] Assets and Liabilities - Total assets increased by 70.12% to ¥5,015,377,025.09 compared to the end of the previous year[14] - The total assets amounted to ¥5,015,377,025.09, an increase from ¥2,948,187,828.29 year-on-year[34] - The total liabilities were ¥412,343,106.64, down from ¥561,634,690.81 in the previous year[34] - The company's cash and cash equivalents at the end of Q1 2023 were ¥2,690,570,078.10, significantly up from ¥521,513,243.59 at the end of Q1 2022[38] Shareholder Equity - Equity attributable to shareholders rose by 92.87% to ¥4,603,033,918.45, driven by new share issuance[14] - The total equity increased to ¥4,603,033,918.45 from ¥2,386,553,137.48 year-on-year, reflecting a robust financial position[34] Non-Recurring Items - Non-recurring gains and losses amounted to ¥9,770,424.68, with government subsidies contributing ¥8,578,984.76[15] Economic Factors - The decline in revenue and profit was attributed to macroeconomic factors such as tightening monetary policy and inflation, despite a slight increase in product sales[16] Other Income and Expenses - The company reported other income of CNY 9,154,336.87, an increase from CNY 6,797,116.34 year-over-year[24] - Income tax expense for the quarter was CNY 24,044,598.52, down 50% from CNY 48,589,862.59 in the previous year[24] - Investment income for the quarter was CNY 1,840,560.44, a decrease from CNY 4,394,000.00 year-over-year[24] - The company had a credit impairment loss of CNY -170,660.66, indicating a negative impact on financial performance[24] Research and Development - Research and development expenses for Q1 2023 were ¥18,133,118.74, a decrease of 34.8% from ¥27,785,362.29 in Q1 2022[36] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 36,087, with the largest shareholder holding 10.12% of the shares[29] Financing Activities - The company raised ¥2,082,666,678.53 from financing activities, indicating strong capital inflow[38]

Financial Performance - The company achieved operating revenue of 3.312 billion RMB, a year-on-year increase of 30.62%[49]. - Net profit reached 1.04 billion RMB, reflecting a year-on-year growth of 52.16%[49]. - Operating cash flow net amount was 1.322 billion RMB, up 189.88% compared to the previous year[49]. - Domestic sales of functional silane products were 44,800 tons, a 12.21% increase year-on-year, generating 1.384 billion RMB in revenue[49]. - Overseas revenue amounted to 1.916 billion RMB, a 35.56% increase year-on-year, despite a 2.83% decline in export volume[49]. - The company reported a total revenue of 1,270.93 million CNY for the year, with no changes in shareholding for key executives[199]. - The company's operating revenue for the current period is 331,172.57 million, representing a 30.62% increase compared to the previous year's 253,540.75 million[80]. - Operating costs increased by 20.71%, amounting to 189,796.33 million, up from 157,237.29 million in the previous year[80]. - The gross profit margin for functional silanes was 42.79%, an increase of 4.73 percentage points compared to the previous year[83]. - Revenue from functional silanes was 327,362.03 million, with a year-on-year increase of 30.29%[83]. Research and Development - R&D expenses totaled 117 million RMB, accounting for 3.5% of operating revenue, with 18 projects under research[49]. - The company applied for 6 invention patents and obtained 3 during the reporting period, totaling 60 granted patents[49]. - The company has a total of 116 R&D personnel, accounting for 12.34% of the total workforce[91]. - The total R&D investment for the period is 11,723.21 million RMB, representing 3.54% of operating revenue[111]. - The company is the largest investor in R&D within the domestic functional silane industry, with a high proportion of high-value-added products[53]. - The company is committed to enhancing R&D efforts for new products and processes, particularly in functional silanes for renewable energy applications[181]. Market and Sales - The company has established long-term strategic partnerships with major global clients, including the top ten tire manufacturers, distributing products to over 80 countries[53]. - The company has a planned production capacity of 6,000 tons/year for functional silane intermediates, with a year-on-year production increase of 19.60%[105]. - The company has established a complete functional silane industry chain with over 100 varieties, achieving significant market share in both domestic and international markets[53]. - The company maintains a high customer loyalty rate, with zero loss of key clients during the reporting period[53]. - The company is focusing on expanding its market share in the functional silane industry, which is expected to continue to grow in the coming years[157]. Financial Management - The company’s financial report received a standard unqualified audit opinion from Tianjian Accounting Firm[11]. - The company emphasizes the importance of accurate financial reporting and has ensured that its annual report is free from false statements or omissions[10]. - The company’s financial expenses showed a significant decrease of 726.13%, resulting in -10,833.02 million compared to 1,730.15 million in the previous year[80]. - The company reported a significant increase in retained earnings to 167,622.93 million, which is 56.86% of total assets, reflecting a 163.21% increase due to improved operating performance[115]. - The company’s approach to investment loss recognition includes adjustments to capital reserves and retained earnings as necessary[197]. Risks and Challenges - The company faces risks related to raw material price fluctuations, which could impact gross margins and profitability if costs cannot be passed on to customers[14]. - The company has identified potential risks in project implementation that could affect investment returns and net asset yield if not managed properly[14]. - The company faces capacity constraints that may hinder its ability to meet increasing market demand, impacting future competitiveness[53]. - The tightening monetary policies in developed economies have negatively impacted the functional silane industry, increasing production and consumption costs[51]. - The company operates in a capital and technology-intensive industry with significant entry barriers, but may face increased competition if market demand slows down[162]. - The company is subject to increasing environmental regulations, which may require additional investments in environmental protection equipment[162]. Corporate Governance - The company has a robust corporate governance structure, ensuring compliance with relevant laws and regulations[167]. - The company has established a strict confidentiality mechanism to protect its core technologies, which are critical to its competitive advantage[162]. - The company has not experienced any changes in shareholding for its executives, indicating stability in management[199]. - The company’s independent directors received a nominal remuneration of 15.00 million CNY each, reflecting a consistent compensation structure[199]. Production and Capacity - The company achieved a capacity utilization rate of 96.88% for functional silane production[49]. - The newly completed 60,000-ton trichlorosilane project has improved production efficiency and reduced costs through chlorine element recycling[123]. - The annual production capacity of the trichlorosilane project has been completed, increasing the capacity by 60,000 tons per year[146]. - The company plans to add 5,000 tons each of three new silane products in 2023, including 3-aminopropyl triethoxysilane and 3-(2,3-epoxypropoxy) propyl trimethoxysilane[146]. Environmental and Safety - The company has implemented a comprehensive safety production and environmental protection system, investing in facilities to meet stringent safety and environmental regulations[53]. - The company has not reported any significant safety production accidents or major environmental violations during the reporting period[151]. - The company has engaged in foreign exchange derivative transactions to hedge against RMB appreciation risks, locking in expected USD revenue exchange rates[134].

Financial Performance - The company achieved operating revenue of 3.31 billion yuan, an increase of 30.62% year-on-year[6]. - Net profit reached 1.04 billion yuan, reflecting a year-on-year growth of 52.16%[2]. - Operating cash flow net amount was 1.32 billion yuan, up 189.88% compared to the previous year[2]. - The company reported a revenue of 179,876.98 million RMB from direct sales, representing a year-on-year increase of 44.74%[23]. - Revenue from distribution channels reached 150,082.32 million RMB, with a year-on-year growth of 40.54%[23]. - The company reported a significant increase in cash flow from operating activities, with cash received from sales reaching 2.76 billion yuan, a 63.81% increase year-on-year[3]. - The company's total revenue for the current period reached ¥3,311,725,653.72, a significant increase from ¥2,535,407,539.83 in the previous period, representing a growth of approximately 30.5%[177]. - The net profit attributable to the parent company for the current period was ¥1,040,017,286.97, compared to ¥683,523,834.46 in the previous period, indicating a growth of about 52.3%[176]. Research and Development - R&D investment totaled 117.23 million yuan, accounting for 3.54% of operating revenue[17]. - The company has a strong R&D team with 116 personnel, representing 12.34% of the total workforce[18]. - The company is actively involved in setting 14 national and industry standards in the functional silane field[1]. - Research and development expenses for the current period were ¥23,526,978.94, up from ¥19,303,295.72 in the previous period, marking an increase of approximately 21.5%[186]. Production and Capacity - The company has established a complete industrial chain from trichlorosilane to various functional silanes, improving product quality and reducing transportation costs[1]. - The annual production capacity of 60,000 tons of trichlorosilane project is expected to be fully operational soon, alongside the construction of functional silane coupling agents and intermediates[33]. - The company has established new production capacity for trichlorosilane to enhance its industrial chain deployment[32]. - The company aims to develop new functional silane products, focusing on resource utilization, new energy applications, and optimizing synthesis processes to improve production efficiency and reduce costs[33]. Environmental and Safety Measures - The company is expected to obtain ISO14067 product carbon footprint certification in 2023[1]. - The company has not reported any significant safety production accidents or major environmental violations during the reporting period[24]. - The company is committed to enhancing safety and environmental protection measures, including improving safety production standards and monitoring environmental impact[33]. - The company invested 13.779 million yuan in environmental protection during the reporting period[148]. - The company has a wastewater treatment plant with a daily processing capacity of 3,750 tons, and all pollution control facilities operated normally during the reporting period[150]. - The company reduced carbon emissions by 8,291 tons through the use of carbon reduction technologies in production[156]. - The company saved 8.5357 million kWh of electricity and 34,600 GJ of steam through carbon reduction measures during the reporting period[157]. - The company reported zero instances of exceeding pollutant discharge limits in 2022[149]. Financial Management - The accounts receivable balance at the end of the period is RMB 491,333.98, with RMB 446,333.98 due within one year[34]. - The company reported a total sales revenue of RMB 98,255.80 million from the top five customers, accounting for 29.67% of the annual sales[44]. - The top five suppliers contributed RMB 55,240.01 million to the total procurement, representing 31.41% of the annual procurement[46]. - The company has no actual write-offs of receivables during the reporting period, indicating effective management of receivables[55]. - The company is actively managing accounts receivable risks to control exposure effectively[33]. - The total amount of receivables endorsed but not yet due is CNY 326,237,655.88, while the total amount of discounted but not yet due receivables is CNY 22,589,109.22, indicating a total of CNY 348,826,765.10[54]. Governance and Compliance - The company has not disclosed any significant differences in governance compared to regulatory requirements, indicating compliance with corporate governance standards[61]. - The company has established a fair and transparent performance evaluation and incentive mechanism for directors, supervisors, and senior management, ensuring compliance with legal regulations[85]. - The company has implemented a robust investor relations management system to enhance communication with investors[85]. - The company strictly adheres to information disclosure regulations, ensuring timely and accurate information is available to all shareholders[85]. - The company has established a comprehensive internal control system to enhance governance and operational efficiency[85]. - The company has not faced any penalties from securities regulatory authorities in the past three years[101]. Employee Management - The company employed a total of 940 staff members, with 707 in production, 116 in technical roles, and 28 in sales[111]. - The average salary for employees (excluding key management) is higher than the average salary of urban workers in Jingzhou City during the same period[112]. - The total employee compensation payable at the end of the period was CNY 192,722,430.71, compared to CNY 264,720,953.37 at the beginning of the period, indicating a decrease of about 27%[82]. - The company has established a training plan that covers all levels of management and frontline employees, promoting a culture of learning[113]. Market and Risk Management - The company faces risks related to product exports, with over 50% of its market structure in foreign markets, which may be affected by trade protectionism policies and international market fluctuations[57]. - The company is exposed to foreign exchange risks due to high export revenue, with potential significant impacts on financial status from RMB appreciation[57]. - The company aims to enhance market analysis, customer management, and risk management to navigate the economic downturn effectively[33].

首次公开发行 A 股股票上市公告书 保荐机构（主承销商） 股票简称：江瀚新材 股票代码：603281 湖北江瀚新材料股份有限公司 Hubei Jianghan New Materials Co.,Ltd. （湖北省荆州市沙市经济开发区群力大道 36 号） 2 第一节 重要声明与提示 本公司及全体董事、监事、高级管理人员保证上市公告书所披露信息的真实、 准确、完整，承诺上市公告书不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 二零二三年一月 1 特别提示 湖北江瀚新材料股份有限公司（以下简称"江瀚新材"、"本公司"或"公 司"）股票将于 2023 年 1 月 31 日在上海证券交易所上市。本公司提醒投资者应 充分了解股票市场风险及本公司披露的风险因素，在新股上市初期切忌盲目跟风 "炒新"，应当审慎决策、理性投资。 上海证券交易所、其他政府机关对本公司股票上市及有关事项的意见，均不 表明对本公司的任何保证。 本公司提醒广大投资者注意，凡本上市公告书未涉及的有关内容，请投资者 查阅刊载于上海证券交易所网站（http://www.sse ...

湖北江瀚新材料股份有限公司（以下简称"发行人"）首次公开发行人民币普 通股（A 股）（以下简称"本次发行"）的申请已获中国证券监督管理委员会核准， 本次发行的保荐机构（主承销商）为中信证券股份有限公司（以下简称"中信证 券"、"保荐机构（主承销商）"）。 发行人的股票简称为"江瀚新材"，股票代码为"603281"。 本次发行采用网下向符合条件的投资者询价配售（以下简称"网下发行"） 和网上向持有上海市场非限售 A 股股份和非限售存托凭证一定市值的社会公众 投资者定价发行（以下简称"网上发行"）相结合的方式进行。 湖北江瀚新材料股份有限公司 首次公开发行股票发行结果公告 保荐机构（主承销商）:中信证券股份有限公司 发行人和保荐机构（主承销商）综合考虑发行人基本面、所处行业、可比上 市公司估值水平、市场情况、募集资金需求及承销风险等因素，协商确定本次发 行价格为 35.59 元/股，发行数量为 66,666,667 股。 回拨机制启动前，网下初始发行数量为 40,000,667 股，约占本次发行总量的 60.00%；网上初始发行数量为 26,666,000 股，约占本次发行总量的 40.00%。回 拨机制启动后， ...

湖北江瀚新材料股份有限公司 Hubei Jianghan New Materials Co.,Ltd. 首次公开发行A股股票招股说明书 保荐机构（主承销商） （湖北省荆州市沙市经济开发区群力大道36号） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 湖北江瀚新材料股份有限公司 首次公开发行股票招股说明书 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | | --- | --- | --- | | 发行股数 | 6,666.6667 万股 | | | 每股面值 | 人民币 元 1.00 | | | 每股发行价格 | 35.59 元 | | | 发行日期 | 2023 年 1 月 13 | 日 | | 拟上市的证券交易所 | 上海证券交易所 | | | 发行后总股本 | 26,666.6667 万股 | | 一、发行数量及发行主体 本次由公司公开发行人民币普通股 6,666.6667 万股，公司股东不公开发售股 份，公开发行股票的总量占公司发行后总股本的比例为 25%。 公司本次公开发行股票所募集资金全部用于与公司主营业务相关的投资项 目和补充流动资金等一般用途。 二、本次发行前股 ...

湖北江瀚新材料股份有限公司 Hubei Jianghan New Materials Co.,Ltd. 首次公开发行A股股票招股说明书摘要 保荐机构（主承销商） 1 （湖北省荆州市沙市经济开发区群力大道36号） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 湖北江瀚新材料股份有限公司 招股说明书摘要 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | | | | --- | --- | --- | --- | --- | | 发行股数 | 6,666.6667 | | 万股 | | | 每股面值 | 人民币 1.00 | | 元 | | | 每股发行价格 | 35.59 | 元 | | | | 发行日期 | 年 月 2023 | 1 | 13 | 日 | | 拟上市的证券交易所 | 上海证券交易所 | | | | | 发行后总股本 | 26,666.6667 | | 万股 | | 一、发行数量及发行主体 本次由公司公开发行人民币普通股 6,666.6667 万股，公司股东不公开发售股 份，公开发行股票的总量占公司发行后总股本的比例为 25%。 公司本次公开发行股票所募集资金全部用 ...

湖北江瀚新材料股份有限公司 Hubei Jianghan New Materials Co.,Ltd. （湖北省荆州市沙市经济开发区群力大道36号） 首次公开发行A股股票招股意向书 保荐机构（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 湖北江瀚新材料股份有限公司 招股意向书 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | | --- | --- | --- | | 拟发行股数 | 万股 6,666.6667 | | | 每股面值 | 人民币 1.00 元 | | | 每股发行价格 | 【●】元 | | | 预计发行日期 | 年 月 日 2023 13 | 1 | | 拟上市的证券交易所 | 上海证券交易所 | | | 发行后总股本 | 万股 26,666.6667 | | 一、发行数量及发行主体 本次拟由公司公开发行人民币普通股 6,666.6667 万股，公司股东不公开发售 股份，公开发行股票的总量占公司发行后总股本的比例为 25%。 公司本次公开发行股票所募集资金全部用于与公司主营业务相关的投资项 目和补充流动资金等一般用途。 二、本次发行前股东对所持股份的 ...